Prader-Willi Syndrome and Hypogonadism: A Review Article

Int J Mol Sci. 2021 Mar 8;22(5):2705. doi: 10.3390/ijms22052705.

Abstract

Prader-Labhart-Willi syndrome (PWS) is a rare genetic disorder characterized by intellectual disability, behavioural problems, hypothalamic dysfunction and specific dysmorphisms. Hypothalamic dysfunction causes dysregulation of energy balance and endocrine deficiencies, including hypogonadism. Although hypogonadism is prevalent in males and females with PWS, knowledge about this condition is limited. In this review, we outline the current knowledge on the clinical, biochemical, genetic and histological features of hypogonadism in PWS and its treatment. This was based on current literature and the proceedings and outcomes of the International PWS annual conference held in November 2019. We also present our expert opinion regarding the diagnosis, treatment, care and counselling of children and adults with PWS-associated hypogonadism. Finally, we highlight additional areas of interest related to this topic and make recommendations for future studies.

Keywords: Prader-Willi syndrome; adult; child; diagnosis; hypogonadism; review; substitution; treatment.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Hypogonadism* / diagnosis
  • Hypogonadism* / genetics
  • Hypogonadism* / metabolism
  • Hypogonadism* / therapy
  • Male
  • Prader-Willi Syndrome* / diagnosis
  • Prader-Willi Syndrome* / genetics
  • Prader-Willi Syndrome* / metabolism
  • Prader-Willi Syndrome* / therapy
  • Puberty*